Protagenic Therapeutics, Inc.\new Payments to Acquire Productive Assets
Protagenic Therapeutics, Inc.\new (PTIX) reported Payments to Acquire Productive Assets of $3.30 thousand for the 12-month period ending 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireProductiveAssets · last filed 2026-08-14
- Protagenic Therapeutics, Inc.\new payments to acquire productive assets for the quarter ending 2023-12-31 was $93.97K.
- Protagenic Therapeutics, Inc.\new payments to acquire productive assets for fiscal 2026 was $3.30K.
- Protagenic Therapeutics, Inc.\new payments to acquire productive assets for fiscal 2023 was $149.78K, a 8197.78% increase from fiscal 2022.
- Protagenic Therapeutics, Inc.\new payments to acquire productive assets for fiscal 2022 was $1.80K.
| Period end | Payments to Acquire Productive Assets 3 month | Payments to Acquire Productive Assets 9 month | Payments to Acquire Productive Assets 12 month |
|---|---|---|---|
| 2026-03-31 | $3.30K 10-K · filed 2026-08-14 | ||
| 2023-12-31 | $93.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $149.78K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $55.81K 10-Q · filed 2024-11-14 | ||
| 2022-12-31 | $1.80K 10-K/A · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |